Russell Angus C. 4
4 · Revance Therapeutics, Inc. · Filed Dec 15, 2021
Insider Transaction Report
Form 4
Russell Angus C.
Director
Transactions
- Purchase
Common Stock
2021-12-13$15.74/sh+6,400$100,741→ 26,913 total
Footnotes (1)
- [F1]The price reported in Table 1, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.65 to $15.81. Mr. Russell undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.